• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹腔镜活体供肾肾切除术的全身肝素化

Systemic heparinisation in laparoscopic live donor nephrectomy.

作者信息

Crotty Charlotte, Tabbakh Yasmin, Hosgood Sarah A, Nicholson Michael L

机构信息

Transplant Group, Department of Infection, Immunity and Inflammation, Leicester General Hospital, University of Leicester, Leicester LE5 4PW, UK.

出版信息

J Transplant. 2013;2013:138926. doi: 10.1155/2013/138926. Epub 2013 Dec 16.

DOI:10.1155/2013/138926
PMID:24455192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3876905/
Abstract

Introduction. Systemic heparinisation is advocated during laparoscopic live donor nephrectomy (LDN) as a preventative measure against renal vascular thrombosis during the warm ischaemic interval. This study compares the outcome with and without the administration of systemic heparinisation. Methods. A retrospective analysis was performed on 186 consecutive LDN patients between April 2008 and November 2012. Systemic heparin (2000-3000 IU) was administered intravenously to donors (hep n = 109). From January 2010, heparin was not used systemically in this group of LDN (no hep n = 77). Outcome measures included donor and recipient complications, initial graft function, and 12 month graft survival. Results. The demographics of both heparinised and non-heparinised donors were similar. The warm ischaemic time (WIT) was comparable in both groups (WIT; hep 5 ± 3 versus no hep 5 ± 3 minutes; P = 1.000). There was no difference in complication rates, no episodes of graft thrombosis, and no incidences of primary nonfunction in either group. Delayed graft function occurred in 4/109 and 1/77 (3.6% versus 1.2%; P = 0.405) and there was no significant difference in graft survival (P = 0.650). Conclusion. Omitting systemic heparinisation during laparoscopic donor nephrectomy is a feasible and safe approach that does not compromise donor or recipient outcome.

摘要

引言。在腹腔镜活体供肾肾切除术(LDN)期间提倡进行全身肝素化,作为在热缺血期预防肾血管血栓形成的一项措施。本研究比较了给予和未给予全身肝素化的结果。方法。对2008年4月至2012年11月期间连续的186例LDN患者进行回顾性分析。向供者静脉注射全身肝素(2000 - 3000国际单位)(肝素组n = 109)。从2010年1月起,该组LDN患者未全身使用肝素(无肝素组n = 77)。观察指标包括供者和受者的并发症、移植肾初始功能以及移植肾12个月生存率。结果。肝素化和未肝素化供者的人口统计学特征相似。两组的热缺血时间(WIT)相当(WIT;肝素组5 ± 3分钟 vs 无肝素组5 ± 3分钟;P = 1.000)。两组在并发症发生率、无移植肾血栓形成事件以及无原发性无功能发生率方面均无差异。移植肾功能延迟恢复分别发生在4/109和1/77例患者中(3.6% 对 1.2%;P = 0.405),移植肾生存率也无显著差异(P = 0.650)。结论。在腹腔镜供肾肾切除术中省略全身肝素化是一种可行且安全的方法,不会影响供者或受者的结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dcf/3876905/9d03500f2034/JTRAN2013-138926.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dcf/3876905/9d03500f2034/JTRAN2013-138926.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dcf/3876905/9d03500f2034/JTRAN2013-138926.001.jpg

相似文献

1
Systemic heparinisation in laparoscopic live donor nephrectomy.腹腔镜活体供肾肾切除术的全身肝素化
J Transplant. 2013;2013:138926. doi: 10.1155/2013/138926. Epub 2013 Dec 16.
2
Laparoscopic live-donor nephrectomy: a comparison with the open technique and how to reach quality standards: a single-center experience in Thailand.腹腔镜活体供肾肾切除术:与开放手术技术的比较以及如何达到质量标准:泰国单中心经验
Transplant Proc. 2011 Dec;43(10):3593-8. doi: 10.1016/j.transproceed.2011.08.115.
3
No need for systemic heparinization during laparoscopic donor nephrectomy with short warm ischemia time.腹腔镜供肾切取术时,若热缺血时间较短,则无需进行全身肝素化。
World J Urol. 2011 Aug;29(4):561-6. doi: 10.1007/s00345-011-0704-1. Epub 2011 May 24.
4
Impact of intraoperative heparin on laparoscopic donor nephrectomy.术中肝素对腹腔镜供肾切除术的影响。
J Urol. 2005 Jul;174(1):226-8. doi: 10.1097/01.ju.0000162048.15746.52.
5
Increased transplantation of kidneys with multiple renal arteries in the laparoscopic live donor nephrectomy era: surgical technique and surgical and nonsurgical donor and recipient outcomes.腹腔镜活体供肾肾切除术时代多条肾动脉肾脏移植增加:手术技术及供受者手术和非手术结局
Arch Surg. 2001 Aug;136(8):897-907. doi: 10.1001/archsurg.136.8.897.
6
Development of laparoscopic donor nephrectomy: a strategy to increase living kidney donation incentive and maintain equivalent donor/recipient outcome.腹腔镜供肾切除术的发展:一种增加活体肾捐献动机并维持供体/受体等效结局的策略。
J Formos Med Assoc. 2009 Feb;108(2):135-45. doi: 10.1016/S0929-6646(09)60044-9.
7
Laparoscopic Live Donor Nephrectomy: Single-Center Experience of 200 Consecutive Cases.腹腔镜活体供肾切除术:200 例连续病例的单中心经验。
J Laparoendosc Adv Surg Tech A. 2021 Jun;31(6):627-631. doi: 10.1089/lap.2020.0545. Epub 2020 Jul 27.
8
Laparoscopic donor nephrectomy: impact on an established renal transplant program.腹腔镜供体肾切除术:对一个成熟肾移植项目的影响。
Am Surg. 2000 Dec;66(12):1132-5.
9
Safety and Efficacy of Retroperitoneoscopic Living Donor Nephrectomy: Comparison of Early Complication, Donor and Recipient Outcome with Hand-Assisted Laparoscopic Living Donor Nephrectomy.后腹腔镜活体供肾切除术的安全性和有效性:与手助腹腔镜活体供肾切除术相比,早期并发症、供体和受者结局的比较。
J Endourol. 2018 Dec;32(12):1120-1124. doi: 10.1089/end.2018.0669.
10
Fate of donor kidney: laparoscopic versus open technique.供体肾的转归:腹腔镜技术与开放技术对比
J Urol. 2004 Dec;172(6 Pt 1):2326-30. doi: 10.1097/01.ju.0000144716.30222.12.

引用本文的文献

1
Aggravation of fibrin deposition and microthrombus formation within the graft during kidney transplantation.在肾移植过程中,移植物内纤维蛋白沉积和微血栓形成加重。
Sci Rep. 2021 Sep 23;11(1):18937. doi: 10.1038/s41598-021-97629-1.

本文引用的文献

1
Identification of risk factors for vascular thrombosis may reduce early renal graft loss: a review of recent literature.识别血管血栓形成的风险因素可能会减少早期肾移植丢失:近期文献综述
J Transplant. 2012;2012:793461. doi: 10.1155/2012/793461. Epub 2012 May 31.
2
Laparoscopic versus open nephrectomy for live kidney donors.活体肾供体的腹腔镜肾切除术与开放性肾切除术对比
Cochrane Database Syst Rev. 2011 Nov 9(11):CD006124. doi: 10.1002/14651858.CD006124.pub2.
3
No need for systemic heparinization during laparoscopic donor nephrectomy with short warm ischemia time.
腹腔镜供肾切取术时,若热缺血时间较短,则无需进行全身肝素化。
World J Urol. 2011 Aug;29(4):561-6. doi: 10.1007/s00345-011-0704-1. Epub 2011 May 24.
4
Live donor nephrectomy: a review of evidence for surgical techniques.活体供肾切除术:手术技术证据的综述。
Transpl Int. 2010 Feb;23(2):121-30. doi: 10.1111/j.1432-2277.2009.01027.x. Epub 2009 Dec 10.
5
Randomized clinical trial of laparoscopic versus open donor nephrectomy.腹腔镜与开放性供体肾切除术的随机临床试验。
Br J Surg. 2010 Jan;97(1):21-8. doi: 10.1002/bjs.6803.
6
Laparoscopic procurement of single versus multiple artery kidney allografts: is long-term graft survival affected?腹腔镜下获取单支动脉与多支动脉供肾移植:长期移植物存活率受影响吗?
Transplantation. 2009 Nov 27;88(10):1203-7. doi: 10.1097/TP.0b013e3181ba343a.
7
Laparoscopic living donor nephrectomy: a look at current trends and practice patterns at major transplant centers across the United States.腹腔镜活体供肾切除术:美国主要移植中心的当前趋势和实践模式观察
J Urol. 2008 Apr;179(4):1488-92. doi: 10.1016/j.juro.2007.11.066. Epub 2008 Mar 4.
8
Effect of warm ischemia on graft outcome in laparoscopic donor nephrectomy.热缺血对腹腔镜供肾切除术移植肾结局的影响。
J Endourol. 2006 Nov;20(11):895-8. doi: 10.1089/end.2006.20.895.
9
Proposed classification of complications after live donor nephrectomy.活体供肾肾切除术后并发症的拟议分类。
Urology. 2006 May;67(5):927-31. doi: 10.1016/j.urology.2005.11.023.
10
More than 500 consecutive laparoscopic donor nephrectomies without conversion or repeated surgery.超过500例连续的腹腔镜供体肾切除术,无中转开腹或再次手术情况。
Arch Surg. 2005 Sep;140(9):835-9; discussion 839-40. doi: 10.1001/archsurg.140.9.835.